Simon N. Pimstone $XENE SEC Form 4 Insider Trading

Simon N. Pimstone has filed a total of 31 insider trades in $XENE since 2021. Their most recent trade was a sale of 24,255 shares, made on Jun 01, 2023. Their largest trade was a sale of 47,000 shares, made on Aug 12, 2022. We estimate that they now own 6,000 shares of $XENE, worth an estimated $252,000.

Insider Trading at $XENE

There have been a total of 84 insider trades reported at $XENE since 2021, with 4,700 shares purchased and 899,930 shares sold. The most active insider traders in $XENE stock have been Ian Mortimer, Sherrington Robin, and James R. Empfield. The most recent trade was a sale of 2,062 shares reported by IAN MORTIMER (PRESIDENT & CEO), made on Jan 02, 2026.

$XENE Executives and Stock Owners with Insider Trades

• Ian Mortimer, PRESIDENT & CEO

• Sherrington Robin, EVP, Strategy & Innovation

• James R. Empfield, EVP, Drug Discovery

• Sherry Aulin, Chief Financial Officer

• Christopher John Kenney, Chief Medical Officer

• Ian Mortimer, PRESIDENT, CEO & INTERIM CFO

• Seggern Christopher Von, Chief Commercial Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.